BioSyent (CVE:RX) Stock Price Crosses Above 50 Day Moving Average – Should You Sell?

BioSyent Inc. (CVE:RX) shares passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$14.49 and traded as high as C$15.25. BioSyent shares last traded at C$15.25, with a volume of 385 shares changing hands.

BioSyent Stock Up 1.6%

The firm’s fifty day moving average is C$14.49 and its 200-day moving average is C$14.56. The company has a market capitalization of C$172.81 million, a P/E ratio of 19.45 and a beta of 1.00. The company has a debt-to-equity ratio of 11.66, a quick ratio of 6.91 and a current ratio of 1.89.

Insider Buying and Selling at BioSyent

In other BioSyent news, Director Seyed Ahmad Ashrafi sold 1,884 shares of the business’s stock in a transaction on Tuesday, June 30th. The shares were sold at an average price of C$14.65, for a total transaction of C$27,600.60. Following the sale, the director owned 37,261 shares of the company’s stock, valued at approximately C$545,873.65. The trade was a 4.81% decrease in their ownership of the stock. Insiders have sold a total of 4,358 shares of company stock worth $63,132 over the last quarter. Insiders own 33.65% of the company’s stock.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis.